Left main interventions with BRSs

Everaert, Bert; Capranzano, Piera; Tamburino, Corrado; Seth, Ashok; Van Geuns, Robert-Jan M.

doi:10.1201/9781315380629

B. Everaert (Bert), P. Capranzano (Piera), C. Tamburino (Corrado), A. Seth (Ashok) and Van Geuns, R.-J.M. (Robert-Jan M.)

2017

Left main interventions with BRSs

Percutaneous coronary intervention (PCI) has become a reliable revascularization option to treat advanced coronary artery disease (CAD) [1]. Several recent trials suggest that PCI with metallic drug-eluting stents (DESs) is feasible and safe and has equivalent long-term outcomes compared to coronary artery bypass grafting (CABG) for the treatment of lesser complex LM stenosis [2,3].

Additional Metadata
Persistent URL	doi.org/10.1201/9781315380629, hdl.handle.net/1765/111590
Rights	no subscription
Organisation	Department of Cardiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Everaert, B., Capranzano, P., Tamburino, C., Seth, A., & Van Geuns, R.-J.M. (Robert-Jan M.). (2017). Left main interventions with BRSs. In Bioresorbable Scaffolds: From Basic Concept to Clinical Applications (pp. 326–331). doi:10.1201/9781315380629

Left main interventions with BRSs

Publication

Publication

About

Left main interventions with BRSs

Publication

Publication

Workflow

Workflow

Add Content